{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:37:43Z","timestamp":1789580263785,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Organon Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002538"],"award-info":[{"award-number":["UL1TR002538"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1TR001067"],"award-info":[{"award-number":["1TR001067"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24HD087436"],"award-info":[{"award-number":["K24HD087436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023100","name":"State of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K01HS02722"],"award-info":[{"award-number":["K01HS02722"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.contraception.2024.110370","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:17:03Z","timestamp":1705792623000},"page":"110370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study"],"prefix":"10.1016","volume":"132","author":[{"given":"Lori M.","family":"Gawron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica B.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Turok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2024.110370_bib1","unstructured":"Centers for Disease Control and Prevention. Key statistics from the National Survey of Family Growth. Available at: \u3008https:\/\/www.cdc.gov\/nchs\/nsfg\/key_statistics\/c_2015\u20132017.htm#currentuse\u3009\u00a0(accessed\u00a0January 12,\u00a02023)."},{"issue":"4","key":"10.1016\/j.contraception.2024.110370_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2024.110370_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2017.01.004","article-title":"Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index","volume":"95","author":"Praditpan","year":"2017","journal-title":"Contraception"},{"issue":"9714","key":"10.1016\/j.contraception.2024.110370_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.contraception.2024.110370_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa2022141","article-title":"Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception","volume":"384","author":"Turok","year":"2021","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1016\/j.contraception.2024.110370_bib6","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/humrep\/det330","article-title":"Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle","volume":"28","author":"Turok","year":"2013","journal-title":"Hum Reprod"},{"issue":"RR-4","key":"10.1016\/j.contraception.2024.110370_bib7","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.contraception.2024.110370_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2018.08.003","article-title":"Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: a prospective cohort study","volume":"98","author":"Edelman","year":"2018","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.contraception.2024.110370_bib9","first-page":"2785","article-title":"A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception","volume":"30","author":"Brache","year":"2015","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.contraception.2024.110370_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/humrep\/dev115","article-title":"The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study","volume":"30","author":"Cameron","year":"2015","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.contraception.2024.110370_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/AOG.0000000000001627","article-title":"Effects of depot medroxyprogesterone acetate injection timing on medication abortion efficacy and repeat pregnancy: a randomized controlled trial","volume":"128","author":"Raymond","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2024.110370_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/AOG.0000000000001274","article-title":"Effect of immediate versus delayed insertion of etonogestrel implants on medication abortion efficacy and repeat pregnancy: a randomized controlled trial","volume":"127","author":"Raymond","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110370_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0010-7824(93)90042-6","article-title":"Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel","volume":"47","author":"Davies","year":"1993","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.contraception.2024.110370_bib14","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/humrep\/deq157","article-title":"Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture","volume":"25","author":"Brache","year":"2010","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.contraception.2024.110370_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2005.06.071","article-title":"Feasibility study of nestorone-ethinylestradiol vaginal contraceptive ring for emergency contraception","volume":"73","author":"Croxatto","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2024.110370_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.contraception.2004.05.007","article-title":"Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation","volume":"70","author":"Croxatto","year":"2004","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2024.110370_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4097\/kjae.2017.70.6.601","article-title":"Introduction of a pilot study","volume":"70","author":"In","year":"2017","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.contraception.2024.110370_bib18","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.contraception.2024.110370_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0010-7824(96)00273-9","article-title":"Menstrual bleeding patterns in untreated women","volume":"55","author":"Belsey","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110370_bib20","article-title":"The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive","volume":"3","author":"Schickler","year":"2021","journal-title":"Contracept X"},{"key":"10.1016\/j.contraception.2024.110370_bib21","unstructured":"ARUP Laboratories\u00a0A.\u00a0Estradiol (Adult premenopausal females or individuals on estrogen hormoe therapy). Available at: \u3008https:\/\/ltd.aruplab.com\/Tests\/Pub\/0070045\u3009\u00a0(accessed\u00a0December 24,\u00a02023)."},{"key":"10.1016\/j.contraception.2024.110370_bib22","unstructured":"ARUP Laboratories\u00a0A. Progesterone quantitative by HPLC-MS, Serum or plasma. Available at: \u3008https:\/\/ltd.aruplab.com\/Tests\/Pub\/2008509\u3009\u00a0(accessed\u00a0December 24,\u00a02023)."},{"key":"10.1016\/j.contraception.2024.110370_bib23","unstructured":"ARUP Laboratories\u00a0A. Luteinizing hormone, Serum. Available at: \u3008https:\/\/ltd.aruplab.com\/Tests\/Pub\/0070093\u3009\u00a0(accessed\u00a0December 24,\u00a02023)."},{"issue":"5","key":"10.1016\/j.contraception.2024.110370_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.contraception.2013.05.010","article-title":"Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens","volume":"88","author":"Brache","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2024.110370_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0010-7824(01)00299-2","article-title":"Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function","volume":"65","author":"Croxatto","year":"2002","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2024.110370_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1752-8062.2011.00347.x","article-title":"Recommendations for planning pilot studies in clinical and translational research","volume":"4","author":"Moore","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.contraception.2024.110370_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2022.04.002","article-title":"Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84-day ulipristal acetate regimens","volume":"112","author":"Westhoff","year":"2022","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2024.110370_bib28","first-page":"71","article-title":"Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting","volume":"76","author":"Fujimoto","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110370_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"Edelman","year":"2016","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078242400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:22Z","timestamp":1762117942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078242400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":29,"alternative-id":["S001078242400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110370","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110370"}}